Search Result "Analogues of arginine vasopressin (AVP)"
Influence of Conformationally Constrained Amino Acids Replacing Positions 2 and 3 of Arginine Vasopressin (AVP) and Its Analogues on Their Pharmacological Properties
Journal: Protein & Peptide Letters
Volume: 14 Issue: 3 Year: 2007 Page: 213-217
Author(s): Dariusz Sobolewski, Adam Prahl, Izabela Derdowska, Anna Kwiatkowska, Jirina Slaninova, Bernard Lammek
Therapeutic Utilisations of Vasopressin and Oxytocin in Mood Disorders
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 1 Issue: 2 Year: 2007 Page: 157-161
Author(s): Gabrielle Scantamburlo, William Pitchot, Emmanuel Pinto, Marc Ansseau, Jean-Jacques Legros
Vasopressin-Receptor Antagonists: A New Class of Agents for the Treatment of Hyponatremia
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 6 Issue: 3 Year: 2006 Page: 249-258
Author(s): Beatriz R. Olson
Vasopressin and the Cardiovascular System: Receptor Physiology and Clinical Implications
Ebook: Frontiers in Cardiovascular Drug Discovery
Volume: 3 Year: 2016
Author(s): Amit Agrawal
Doi: 10.2174/9781681081632116030005
Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 3 Issue: 2 Year: 2008 Page: 77-93
Author(s): Neal G. Simon, Christophe Guillon, Karine Fabio, Ned D. Heindel, Shi-fang Lu, Marvin Miller, Craig F. Ferris, Michael J. Brownstein, Carrie Garripa, Gary A. Koppel
Vasopressin and Terlipressin in Neonates and Children with Refractory Septic Shock
Journal: Current Drug Metabolism
Volume: 14 Issue: 2 Year: 2013 Page: 186-192
Author(s): Paolo Biban,Marcella Gaffuri
Vasopressin and Related Peptides; Potential Value in Diagnosis, Prognosis and Treatment of Clinical Disorders
Journal: Current Drug Metabolism
Volume: 18 Issue: 4 Year: 2017 Page: 306-345
Author(s): Ewa Szczepanska-Sadowska,Tymoteusz Zera,Piotr Sosnowski,Agnieszka Cudnoch-Jedrzejewska,Anna Puszko,Aleksandra Misicka
The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 2 Year: 2005 Page: 205-225
Author(s): Robert H. Ring
Vasopressin in Health and Disease with a Focus on Affective Disorders
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 12 Issue: 4 Year: 2012 Page: 286-303
Author(s): Dora Zelena
Large A-V Fistula: Pathophysiological Consequences and Therapeutic Perspectives
Journal: Current Vascular Pharmacology
Volume: 1 Issue: 3 Year: 2003 Page: 347-354
Author(s): Zaid A. Abassi, Joseph Winaver, Aaron Hoffman